Postbiotic-based recombinant receptor activator of NF-κB ligand enhanced oral vaccine efficiency in chicken
Applied Microbiology and Biotechnology · 2024
DOI: 10.1007/s00253-024-13237-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Biao Xuan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science, College of Agriculture, Yanbian University, Yanji, 133002, China. Hauptthemen laut MEDLINE: Chickens, Lactococcus lactis, RANK Ligand, Recombinant Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Yanbian University Doctoral Research Startup Fund.
Abstract (Originalsprache)
Functional M cells are differentiated by receptor activator of NF-κB ligand (RANKL) and capture of luminal antigens to initiate immune responses. We aimed to use postbiotic-based recombinant chicken RANKL (cRANKL) to promote M cell differentiation and test the efficacy of oral vaccines. Chicks were divided into three groups that were administered phosphate-buffered saline (PBS), cell extracts of wild-type Lactococcus lactis subsp. lactis IL1403 (WT_CE), or cell extracts of recombinant L. lactis expressing cRANKL (cRANKL_CE). The expression of the M cell marker was measured, and the gut microbiome was profiled. The efficiency of the infectious bursal disease (IBD) vaccine was tested after 12 consecutive days of administering cRANKL_CE. The chickens that were administered cRANKL_CE ( p = 0.038) had significantly higher Annexin A5 ( ANXA5 ) mRNA expression levels than those in the PBS group (PBS vs. WT_CE, p = 0.657). In the gut microbiome analysis, no significant changes were observed. However, the relative abundance of Escherichia-Shigella was negatively correlated ( r = − 0.43, p = 0.019) with ANXA5 mRNA expression in Peyer’s patches. cRANKL_CE/IBD ( p = 0.018) had significantly higher IBD-specific faecal IgA levels than PBS/IBD (PBS/IBD vs. WT_CE/IBD, p = 0.217). Postbiotic-based recombinant cRANKL effectively improved the expression of M cell markers and the efficiency of oral vaccines. No significant changes were observed in the gut microbiome after administration of postbiotic-based recombinant cRANKL. This strategy can be used for the development of feed additives and adjuvants. Key points • Postbiotic-based recombinant cRANKL enhanced the expression of ANXA5 in chicken. • The relative abundance of Escherichia-Shigella was negatively correlated with ANXA5 expression. • Postbiotic-based recombinant cRANKL effectively improved the efficiency of oral vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Science, College of Agriculture, Yanbian University, Yanji, 133002, China.
- Department of Applied Animal Science, College of Animal Life Sciences, Kangwon National University, Kangwon-Do, Chuncheon, 24341, Republic of Korea.
- Korea Research Institute of Bioscience and Biotechnology (KRIBB), Microbiome Convergence Research Center, Daejeon, 34141, South Korea.
- Department of Applied Animal Science, College of Animal Life Sciences, Kangwon National University, Kangwon-Do, Chuncheon, 24341, Republic of Korea. itanimal@kangwon.ac.kr.
Förderung
- National Research Foundation of Korea
- Yanbian University Doctoral Research Startup Fund
Zitieren
APA
Xuan, B., Park, J., Choi, S., & Kim, E. B. (2024). Postbiotic-based recombinant receptor activator of NF-κB ligand enhanced oral vaccine efficiency in chicken. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13237-9
Vancouver
Xuan B, Park J, Choi S, Kim EB. Postbiotic-based recombinant receptor activator of NF-κB ligand enhanced oral vaccine efficiency in chicken. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13237-9
BibTeX
@article{Xuan2024,
author = {Xuan, Biao and Park, Jongbin and Choi, Seojin and Kim, Eun Bae},
title = {Postbiotic-based recombinant receptor activator of NF-κB ligand enhanced oral vaccine efficiency in chicken},
journal = {Applied Microbiology and Biotechnology},
year = {2024},
doi = {10.1007/s00253-024-13237-9}
}
EUVIMED